Shane Albright represents life science and technology companies in a wide range of corporate, financial and commercial matters, with a particular emphasis on complex transactions involving intellectual property.

He has extensive experience counseling clients on corporate partnering issues, strategic alliances, technology licenses and key commercial contracts, such as manufacturing and distribution agreements.

In addition, Shane regularly provides advice on licensing and commercial contract issues in connection with mergers and acquisitions, IPOs and other public financings. He also represents emerging growth companies and their investors in venture financings, other funding transactions and general corporate matters.

Shane’s clients span multiple fields, including companies in the biopharmaceutical, medical device, diagnostics, hardware, software, medical instrumentation, vaccine and research reagent spaces, as well as entities that fund or conduct medical research.